ResearcherBaylor UniversityActive in the last 2 years
Jonathan A. Kelber
Matched on ORCID iD 0000-0002-4606-1445; OpenAlex author ID A5056918379; NIH RePORTER profile ID 9175601. Sources: OpenAlex.
Their work
- Papers
- 7 (first author 0, last author 4)
- Trials
- 0
- Grants
- 1
- Labs led
- 2
- Collaborators
- 14
2012: 1 paper · 2013: none · 2014: 1 paper · 2015: none · 2016: 1 paper · 2017: 3 papers · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: none · 2024: 1 paper · 2025: none · 2026: 1 grant
Papers 7
- Multidimensional screening of pancreatic cancer spheroids reveals vulnerabilities in mitotic and cell-matrix adhesion signaling that associate with metastatic … Last author DOI 10.1016/j.bbrc.2024.149575↗
- ITGA1 is a pre-malignant biomarker that promotes therapy resistance and metastatic potential in pancreatic cancer. Last author DOI 10.1038/s41598-017-09946-z↗
- eIF5A-PEAK1 Signaling Regulates YAP1/TAZ Protein Expression and Pancreatic Cancer Cell Growth. Co-author DOI 10.1158/0008-5472.can-16-2594↗
- A novel method for RNA extraction from FFPE samples reveals significant differences in biomarker expression between orthotopic and subcutaneous pancreatic canc… Last author DOI 10.18632/oncotarget.11809↗
- Cellular and molecular aspects of pancreatic cancer. Last author DOI 10.1016/j.acthis.2016.01.009↗
- A hypusine-eIF5A-PEAK1 switch regulates the pathogenesis of pancreatic cancer. Co-author DOI 10.1158/0008-5472.can-14-1031↗
- KRas induces a Src/PEAK1/ErbB2 kinase amplification loop that drives metastatic growth and therapy resistance in pancreatic cancer. Co-author DOI 10.1158/0008-5472.can-11-3552↗
Grants 1
Closest collaborators
The 14 strongest of 14 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Albert-Fred Aquino · 1 shared paper, 2024 · strength 0.24
- Armen Gharibi · 3 shared papers, 2016–2017 · strength 0.23
- Paper Cellular and molecular aspects of pancreatic cancer. DOI 10.1016/j.acthis.2016.01.009↗
- Paper ITGA1 is a pre-malignant biomarker that promotes therapy resistance and metastatic potential in pancreatic cancer. DOI 10.1038/s41598-017-09946-z↗
- Paper A novel method for RNA extraction from FFPE samples reveals significant differences in biomarker expression between ort… DOI 10.18632/oncotarget.11809↗
- Michael Bouvet · 4 shared papers, 2012–2017 · strength 0.19
- Paper A novel method for RNA extraction from FFPE samples reveals significant differences in biomarker expression between ort… DOI 10.18632/oncotarget.11809↗
- Paper eIF5A-PEAK1 Signaling Regulates YAP1/TAZ Protein Expression and Pancreatic Cancer Cell Growth. DOI 10.1158/0008-5472.can-16-2594↗
- Paper A hypusine-eIF5A-PEAK1 switch regulates the pathogenesis of pancreatic cancer. DOI 10.1158/0008-5472.can-14-1031↗
- Malachia Y. Hoover · 2 shared papers, 2017 · strength 0.13
- Paper ITGA1 is a pre-malignant biomarker that promotes therapy resistance and metastatic potential in pancreatic cancer. DOI 10.1038/s41598-017-09946-z↗
- Paper A novel method for RNA extraction from FFPE samples reveals significant differences in biomarker expression between ort… DOI 10.18632/oncotarget.11809↗
- Richard L. Klemke · 3 shared papers, 2012–2017 · strength 0.13
- Paper eIF5A-PEAK1 Signaling Regulates YAP1/TAZ Protein Expression and Pancreatic Cancer Cell Growth. DOI 10.1158/0008-5472.can-16-2594↗
- Paper A hypusine-eIF5A-PEAK1 switch regulates the pathogenesis of pancreatic cancer. DOI 10.1158/0008-5472.can-14-1031↗
- Paper KRas induces a Src/PEAK1/ErbB2 kinase amplification loop that drives metastatic growth and therapy resistance in pancre… DOI 10.1158/0008-5472.can-11-3552↗
- Ken Fujimura · 2 shared papers, 2014–2017 · strength 0.10
- Ján Strnádel · 2 shared papers, 2014–2017 · strength 0.10
- Robert M. Hoffman · 2 shared papers, 2012–2017 · strength 0.09
- Paper A novel method for RNA extraction from FFPE samples reveals significant differences in biomarker expression between ort… DOI 10.18632/oncotarget.11809↗
- Paper KRas induces a Src/PEAK1/ErbB2 kinase amplification loop that drives metastatic growth and therapy resistance in pancre… DOI 10.1158/0008-5472.can-11-3552↗
- Cristina Angela Metildi · 2 shared papers, 2012–2014 · strength 0.07
- Andrew M. Lowy · 2 shared papers, 2012–2014 · strength 0.07
- Matthew H. G. Katz · 1 shared paper, 2017 · strength 0.06
- Ali A. Maawy · 1 shared paper, 2017 · strength 0.06
- Jason B. Fleming · 1 shared paper, 2017 · strength 0.06
- Kun‐Liang Guan · 1 shared paper, 2017 · strength 0.06
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.